Amphastar Pharma Stock Price (NASDAQ:AMPH)

Add to My Stocks
$19.12 $0.39 (2%) AMPH stock closing price Mar 22, 2018 (Closing)
Prev Close* : $19.51
Market Cap:
Day Low: $19.1
52 Week Low: $13.15
Open: $19.3
Volume: -
Day High: $19.55
52 Week High: $20.45

Latest Stock Market News

Latest Articles

Amphastar Pharma News - From Partners

AMPH Stockcharts

View AMPH PE ratio, PS ratio stocks charts and compare with peers.
AMPH Chart
Note: Compare Amphastar Pharma stock price history with the index and industry peers.

Amphastar Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Amphastar Pharma Returns

(return on equity)

Amphastar Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

AMPH Industry Peers

Company Price Change (%)
Axogen (AXGN)39.550.15 (0.38%)
Bactolac Pharma (BTCA)1200000 (0%)
Teligent (TLGT)3.530.32 (9.97%)
Halozyme Therapeutics (HALO)20.380.56 (2.67%)
Sanofi (SNY)39.430.48 (1.2%)
Novartis (NVS)79.881.2 (1.48%)
Mannkind (MNKD)2.570.07 (2.65%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teligent (TLGT)3.530.32 (9.97%)
AEVI GENOMIC (GNMX)2.030.06 (3.05%)
Aquinox Pharma (AQXP)14.550.11 (0.76%)
AxoGen (AXGN)39.550.15 (0.38%)
Top gainers from Medical-Generic Drugs industry
* As of Mar 23, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)24.461.34 (5.19%)
Mylan (MYL)39.871.29 (3.13%)
Dr. Reddy's Laboratories (RDY)32.370.8 (2.41%)
Mallinckrodt (MNK)14.310.26 (1.78%)
Teva Pharmaceutical (TEVA)17.310.29 (1.65%)
Impax Lab (IPXL)20.50.25 (1.2%)
Corium (CORI)11.520.08 (0.69%)
Top losers from Medical-Generic Drugs industry
* As of Mar 23, 2018

Amphastar Pharmaceuticals Inc Stock News - Partner Headlines

America’s War on Drugs   on Mar 07, 2017

Amphastar Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues255.16M251.51M210.46M229.68M204.32M
Net Income10.53M-2.78M-10.69M11.86M18.09M
Total Operating Expense88.48M84.24M69.23M69.45M64.9M
View Amphastar Pharma income statement
balance sheet20162015201420132012
Total Assets427.73M390.13M389.37M338.74M317.47M
Total Liabilities98.48M94.62M107.51M87.2M84.03M
Shareholders Equity329.25M295.51M281.86M251.54M233.43M
View Amphastar Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities--5.13M15.61M-3.23M-49.64M
Net Cash from (used by) Operating Activities38.56M10.68M21.05M31.04M-1.65M
Increase (Decrease) in Prop Plant And Equipment-21.38M-15.99M-20.49M-18.3M-23.66M
View Amphastar Pharma cash flow statement

Amphastar Pharma Stock Message Board

An investor needs to spend $19.12 to buy AMPH stock, as the closing Amphastar Pharma stock price is $19.12. Looking at Amphastar Pharma market capitalization, which currently stands at $904.3M, we can say that AMPH stock is a Small Cap stock. Amphastar Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Amphastar Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 196,236 AMPH shares were traded yesterday, and Amphastar Pharma stock chart shows that the AMPH stock quote hit a day high of $19.55 and day low of $19.1. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Amphastar Pharma does not pay dividends. Amphastar Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.